News

Updates, product releases, and company news.

• September 18, 2025

  Avenio Beta Launch: Join the 30+ BioPharma's Already...

  Avenio AI launched its Beta version of AvenioGPT, an AI platform for clinical trial operations. The platform helps BioPharma companies accelerate enrollment, streamline site operations, and generate regulatory documents more efficiently.

  Featured in:

  EIN Presswire↗

• August 5, 2025

  Avenio.ai Appoints Dr. Megha Vasavada as VP of Product...

  Avenio.ai has appointed Dr. Megha Vasavada as VP of Product Management to lead product strategy for AvenioGPT, bringing over a decade of experience in clinical research to transform insight generation and decision-making across the clinical trial lifecycle.

  Featured in:

  EIN Presswire↗J. of Business↗

• July 15, 2025

  AvenioGPT Alpha Launch Sparks High Demand Across...

  Avenio Corp launched AvenioGPT, an AI platform for life sciences and clinical research designed to reduce friction, enhance research velocity, and deliver actionable insight across BioPharma workflows, with early demand from 24 BioPharma entities and academic research institutes.

  Featured in:

  EIN Presswire↗CBS42↗

• May 21, 2024

  Avenio Selected for NVIDIA Inception Program

  Avenio joins NVIDIA Inception Program to scale Gen AI powered drug development process to revolutionize BioPharma research, reasoning, and coordination. The program provides access to NVIDIA's cutting-edge AI computing platform and resources to accelerate enterprise-grade BioPharma solutions.

  Featured in:

  EIN Presswire↗US Healthcare↗